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Cardiovascular Effect of
Bans on Smoking in Public Places
A Systematic Review and Meta-Analysis
David G. Meyers, MD, MPH,*† John S. Neuberger, DRPH, MPH, MBA,† Jianghua He, PHD‡
Kansas City, Kansas
Objectives A systematic review and a meta-analysis were performed to determine the association between public smoking
bans and risk for hospital admission for acute myocardial infarction (AMI).
Background Secondhand smoke (SHS) is associated with a 30% increase in risk of AMI, which might be reduced by prohibit-
ing smoking in work and public places.
Methods PubMed, EMBASE, and Google Scholar databases plus bibliographies of relevant studies and reviews were
searched for peer-reviewed original articles published from January 1, 2004, through April 30, 2009, using the
search terms “smoking ban” and “heart” or “myocardial infarct.” Investigators supplied additional data. All pub-
lished peer-reviewed original studies identified were included. Incidence rates of AMI per 100,000 person-years
before and after implementation of the smoking bans and incidence rate ratios (IRRs) with 95% confidence in-
tervals (CIs) were calculated. Random effects meta-analyses estimated the overall effect of the smoking bans.
Funnel plot and meta-regression assessed heterogeneity among studies.
Results Using 11 reports from 10 study locations, AMI risk decreased by 17% overall (IRR: 0.83, 95% CI: 0.75 to 0.92),
with the greatest effect among younger individuals and nonsmokers. The IRR incrementally decreased 26% for
each year of observation after ban implementation.
Conclusions Smoking bans in public places and workplaces are significantly associated with a reduction in AMI incidence,
particularly if enforced over several years. (J Am Coll Cardiol 2009;54:1249–55) © 2009 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.022s
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Secondhand smoke (SHS) increases the risk of acute myocar-
ial infarction (AMI) by 25% to 31% (1–5). In countries where
moking prevalence is high, for example, Britain 50% (6),
urope 62% (7), and Greece 156% (8), versus 22% in the U.S.
2,9), AMI in nonsmokers is particularly increased. The
ose-response relationship between SHS and AMI is nonlin-
ar, increasing rapidly even at low concentrations (10–12).
ans on smoking in public places and workplaces have been
nstituted in several countries, 32 U.S. states, and many cities
nd counties in the U.S. We performed a systematic literature
eview and meta-analysis to estimate the overall effect of public
workplace and public place) smoking bans on the risk of AMI
n the general population.
ethods
e searched PubMed, EMBASE, and Google Scholar
rom January 1, 2004, through April 30, 2009, using the
rom the Departments of *Internal Medicine, †Preventive Medicine and Public
ealth, and ‡Biostatistics, University of Kansas School of Medicine, Kansas City,
ansas.t
Manuscript received May 13, 2009; revised manuscript received July 20, 2009,
ccepted July 28, 2009.earch terms “smoking ban” and “heart” or “myocardial
nfarct” and reviewed pertinent bibliographies. One unpub-
ished abstract and 1 nonpeer-reviewed report were ex-
luded, leaving 11 peer-reviewed published studies concern-
ng 10 geographic locations. Duplicate data abstracting was
erformed by 2 authors (D.G.M. and J.S.N.). Only AMI
ases were included (some investigators supplied additional
ata), except where the case definition was acute coronary
yndrome (ACS), which required an elevated serum troponin.
See page 1256
o avoid duplicate cases (Piedmont and Latium [Rome]
ere separately reported), only the regions of Fruili Venezia
iulia (Trieste) and Campania (Naples) were analyzed from
he Italian study of 4 regions. Results were converted to
ncidence rates (new cases/100,000 person-years) using the
ost recent official census and including all age groups.
Meta-analysis used the random-effects model in the metan
tatistical package in STATA version 10 (Stata Corp., College
tation, Texas) (13) because heterogeneity was significant in
he fixed effects model (p  0.001). Unlike previously pub-
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Cardiovascular Effects of Smoking Ban September 29, 2009:1249–55lished meta-analyses, which used
average yearly incidence rates
(14,15), we weighted studies by
person-years, thus considering
both population size and duration
of observation, and assumed that
the incidence of AMI satisfied a
Poisson process (16). Because the
funnel plot showed systematic
heterogeneity among the study
results, we performed a meta-
regression analysis using the
metareg package of STATA 10
o examine whether the estimate of incidence rate ratio
IRR) depends on such factors as post-ban duration, popula-
ion size, or region (U.S. or non-U.S.).
esults of the Systematic Review
bstractor agreement was 100%. Results are summarized in
able 1. All studies reported decreases in incidence (at least
n a subgroup), with the largest decreases observed in the
.S. Table 2 lists important study parameters based on the
ewcastle-Ottawa scale (17). No study had all parameters,
lthough the Scotland study had nearly all. All studies excluded
ransients and matched observation periods by season.
elena, Montana. This community of 47,154 persons
assed a ban on public smoking (all but 2 businesses complied)
n June 2002, which was judicially suspended in December
002 (18). Investigators screened cases of AMI by Interna-
ional Classification of Diseases (ICD) 9th Edition codes
410xx) and confirmed cases by chart review (criteria not
ublished). Incidence decreased from 170 to 102 cases/100,000
erson-years, then returned to baseline, a 40% temporary
ecline. In the surrounding area, incidence increased from 118
o 172 cases/100,000 person-years, an increase of 46%. This
as the first study of a public smoking ban and the only study
o include data from after a ban was suspended.
ummary Results of Smoking BansTable 1 Summary Results of Smoking Bans
Ban Location
Population Exposed
to Ban
Post-Ban Observation
Period (Yrs) Pre-Ban
U.S.
Helena 68,140 0.5 170
Pueblo 698,229 3.0 257
New York 18,976,457 1.0 483
Indiana 239,332 1.5 14
Ohio 29,636 3.0 277
Canada
Saskatoon 202,340 1.0 176
Europe
Piedmont 4,300,000 0.5 200
Rome 2,663,182 1.0 252
Italy 7,033,451 0.2 159
Scotland§ 3,000,000 0.8 129
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
AMI  acute myocardial
infarction
CI  confidence interval
ICD  International
Classification of Diseases
IRR  incidence rate ratio
SHS  secondhand smokeCases per 100,000 person-years. †The acute myocardial infarction incidence decreased 9.8% in those
ncidence decreased 11% in those age 65 years and decreased 8% in those age 75 to 84 years, particueblo, Colorado. Pueblo (population 103,648) banned
moking in bars, restaurants, bowling alleys, and business
stablishments, whereas Colorado Springs (population
70,448), 45 miles distant in El Paso County, did not (19).
ases included a primary diagnosis of AMI by ICD-9 code
10xx (with no confirmation by biomarkers) for 18 months
efore and the initial 18 months during ban enforcement.
uring the ban, AMI incidence in the city of Pueblo
ecreased by 27% (257 to 187 cases/100,000 person-years,
RR: 0.73, 95% confidence interval [CI]: 0.64 to 0.82). The
urrounding Pueblo County (noncity population 44,103)
ecreased 15% (135 to 115 cases/100,000 person-years,
RR: 0.85, 95% CI: 0.56 to 1.14). Adjacent El Paso County
population 550,478) experienced a 4% decrease (157 to 150
ases/100,000 person-years, IRR: 0.96, 95% CI: 0.87 to
.04). An additional 18 months of observation noted a
urther 19% reduction in Pueblo City (152 cases/100,000
erson-years) for an overall 3-year reduction of 41% (IRR:
.59, 95% CI: 0.49 to 0.70) with no reduction in either
ueblo County (IRR: 1.03, 95% CI: 0.68 to 1.39) or
djacent El Paso County (IRR: 0.95, 95% CI: 0.87 to 1.03)
20). This study used well-separated communities and
hared the longest observation period.
ew York State. Many communities in New York State
population 18,976,457) had banned public smoking, and
he state had increased taxation on tobacco before the July
003 implementation of a statewide ban on work and public
moking (bars, restaurants, and hospitality venues) (21). A
tatewide database (252 hospitals) was searched for the
rimary diagnosis of AMI cases (ICD-9 codes 410.0 to
10.99 with no biomarker confirmation) for 1995 through
004. The AMI incidence decreased 8%, from 483 (46,332
ases) to 445 cases/100,000 person-years (45,412 cases).
ompliance with the ban was 93%. Had there been no local
aws, the comprehensive state law would have been associ-
ted with a 19% decline in admissions. From 2002 to 2004,
ew York City smoking prevalence decreased from 21.5%
Post-Ban Rate*
Incidence Rate Change
in Ban Area
Incidence Rate Change
in Non-Ban Area
102 40% 46%
152 41% 5%
445 8% None
7 50% 20%
223 20% 5%
152 13% None
204 2%† None
253 0%‡ None
149 6% None
107 17% 4%Rate*age 65 years and increased 6.2% in those age 65 years. ‡The acute myocardial infarction
ularly among men. §The end point was acute coronary syndrome.
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September 29, 2009:1249–55 Cardiovascular Effects of Smoking Bano 18.5% (22). Exposure, as measured by salivary cotinine,
ecreased 47% (23). This is the largest population studied.
onroe County, Indiana. Monroe County (population
20,563) banned smoking in all restaurants, retail outlets,
nd workplaces in 2003, but excluded bars until 2005 (24).
elaware County (population 118,769), 90 miles distant,
id not restrict smoking. Cases during 18 months before
nd during the ban were ascertained by ICD-9 codes for
rimary and secondary diagnosis of AMI (410.0x to 410.9x)
nd confirmed with biomarkers. Patients with a “. . .past
ardiac procedure. . .” or who had “. . .comorbidity such as
ypertension and high cholesterol that could have precipi-
ated acute myocardial infarction. . .” were excluded (24).
ase smoking status was ascertained. The AMI incidence
ecreased 50%, from 14 to 7 cases/100,000 person-years.
he Delaware County rate of 15 cases/100,000 person-years
eclined by 20% to 12 cases/100,000 person-years. The
eduction was primarily among nonsmokers, whose admis-
ions decreased 70% (12 cases, 95% CI: 21.2 to 2.8).
he exclusion of subjects with prior cardiac procedures or
isk factors likely reduced AMI incidence.
owling Green, Ohio. Investigators compared admissions
or coronary heart disease (ICD-9 codes 410 to 414 and 428
ncluding angina, heart failure, atherosclerosis, and AMI
ith no biomarker confirmation) in Bowling Green, Ohio
population 29,636), which banned smoking in workplaces
nd public places except bars, to admissions in Kent, Ohio
population 27,906), 150 miles distant with no ban (25).
ospital discharge data for 3 years before and after the ban
6 months immediately after ban implementation were
xcluded) for cases in the 2 cities were obtained from a state
atabase. The AMI incidence in Bowling Green decreased
y 19%, from 277 to 223 cases/100,000 person-years (p 
.015). Incidence in Kent did not significantly change (440
ases/100,000 person-years in 1999 to 2002 and 417 cases/
mportant Study ParametersTable 2 Important Study Parameters
Location
Prospective
Design
Population
>1 Million
Follow-Up
>1 Yr
AMI Primary
Diagnosis
U.S.
Helena
Pueblo  
New York   
Indiana 
Ohio  
Canada
Saskatoon  
Europe
Piedmont  
Rome  
Italy  
Scotland   
MI  acute myocardial infarction; SHS  secondhand smoke.00,000 person-years in 2003 to 2005, p  0.22). This (tudy shared the longest observation period. Only AMI data
upplied by the investigators were used.
askatoon, Canada. Saskatoon (population 202,340) imple-
ented a smoking ban in all enclosed public places and
utdoor seating areas in July 2004. The AMI cases (ICD-9
10.00 to 410.92 and ICD-10 121.1 to 121.9) in the database
f the Strategic Health Information Planning Service were
dentified (no biomarker confirmation) for 1 year during the
an and for the previous 4 years (26). Compliance was 99%.
ncidence of AMI decreased 14%, from 176 (95% CI: 165 to
87 cases/100,000 person-years) to 152 cases/100,000 person-
ears (95% CI: 135 to 169 cases/100,000 person-years). Smok-
ng prevalence was 24% in 2003 and 18% in 2005.
iedmont, Italy. Italy banned smoking in cafes, restau-
ants, bars, and discos in 2005. Investigators used ICD-9
odes (410.xx) in the Hospital Discharge Registry of the
iedmont region (population 4,300,000) to identify AMI
ases (no confirmation) before and during 5 months after
an initiation (27). Before the ban, an average of 3,581
MIs were reported between February and June (200
ases/100,000 person-years). During the comparable 5
onths of ban enforcement, 3,655 cases were reported (204
ases/100,000 person-years). A decrease was observed only
mong women 60 years of age (women IRR: 0.75, 95%
I: 0.58 to 0.96; men IRR: 0.91, 95% CI: 0.83 to 1.01).
ases in persons 60 years of age were unchanged (IRR:
.05, 95% CI: 1.00 to 1.11). The ban was almost universally
bserved (28), nicotine vapor in public places decreased 90%
o 95% (29), cigarette sales declined 8.9% (28), and cigarette
onsumption decreased 7.6% (28). The investigators sug-
ested a greater effect of the ban on younger people and a
ower attributable risk of AMI from smoking among older
eople (27). This study provided age- and sex-specific data.
ome, Italy. Investigators in Rome (population 2,663,182),
sing 2 databases, identified all hospital admissions with a
rimary or secondary diagnosis of ACS, including AMI
Smoking
tatus
ertained
SHS
Measured
Compliance
With the
Ban
Smoking
Prevalence
Contemporaneous
Controls
 

  
 

 
  
 
   Case
S
AscICD-9-CM code 410.xx without biomarker confirmation)
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Cardiovascular Effects of Smoking Ban September 29, 2009:1249–55r other forms of ischemic heart disease (ICD-9-CM code
11) and all out-of-hospital deaths caused by ischemic heart
isease, among persons 34 years of age before and after
nactment of the smoking ban (30). Pre-ban incidence was
52 cases/100,000 person-years. During the ban, incidence
as 253 cases/100,000 person-years. Incidence decreased
ignificantly in 35- to 64-year-old men (IRR: 0.89, 95% CI:
.85 to 0.93) and in 65- to 74-year-old men (IRR: 0.92,
5% CI: 0.88 to 0.97), but not in 75- to 84-year-old men
IRR: 1.02, 95% CI: 0.98 to 1.07). Among women (30% of
MI cases), the decrease was confined to the young (IRR:
.90, 95% CI: 0.81 to 1.00 in 35- to 64-year-old women
nd IRR: 0.95, 95% CI: 0.88 to 1.04 in 65- to 74-year-old
omen). Decreases occurred in indoor particle and urinary
otinine concentrations and per capita cigarette sales,
hereas nicotine replacement product sales increased
31,32). This study adjusted for several confounders, includ-
ng weather and temporal trends. The meta-analysis used
MI data supplied by the investigators.
our regions, Italy. The Italian Health Ministry used re-
ional databases to identify cases (age 40 to 64 years) dis-
harged with AMI (ICD-9 code 410.xx, no biomarker confir-
ation) in 4 regions of Italy with 16,995,734 people
Piedmont, Friuli Venezia Giulia, Latium, and Campania),
epresenting 28% of the Italian population, during correspond-
ng 2-month periods before and during the national ban (33).
he AMI incidence decreased 6%, from 159 to 149 cases/
00,000 person-years. The preceding years had increasing
ates. Reduction in incidence was limited to 45- to 54-year-old
en, an 8% decrease. No sex or age group experienced an
ncrease in AMIs. This study had the shortest observation
eriod. The meta-analysis excluded the regions of Piedmont
nd Latium (Rome), reported separately (27,30).
Figure 1 Effects of Community Smoking Bans on Incident Acut
Meta-analysis results for 11 studies in 10 geographic locations. CI  confidence icotland. Since March 2006, smoking has been prohibited in
ll enclosed public places in Scotland (population 5.1 million).
nvestigators identified all patients admitted to 9 hospitals
catchment area included approximately 3 million persons,
ccounting for 64% of the country’s hospital admissions) for a
iagnosis of ACS from June 2005 through March 2006 and
or the corresponding 10 months after ban institution (34). An
CS was defined as chest pain with “a detectable level of
ardiac troponin,” routinely measured in all cases of chest pain.
ase smoking status was ascertained by self-report and serum
otinine levels, which allowed estimation of passive exposure to
HS. Results were compared with admissions in England,
hich did not have a ban. In the 10 months before the ban,
,235 patients were admitted. After the ban, 2,684 patients
ere admitted, a 17% decrease (95% CI: 16% to 18%).
ngland experienced a 4% decrease. In Scotland, admissions
ecreased by 14% in smokers, 19% in former smokers, and
1% in never smokers. The investigators estimated that 67% of
he admissions prevented involved nonsmokers. Nonsmokers
eporting exposure to SHS decreased from 43% to 22%. Serum
otinine levels decreased by 18%. Compliance was 98%: SHS
n bars decreased by 86% within 2 weeks of ban implementa-
ion (35). This is the only prospective study and used both
irect and indirect measurement of exposure.
esults of the Meta-Analysis
s shown in Figure 1, the overall IRR comparing AMI
efore and after smoking bans is 0.83 (95% CI: 0.75 to
.92), indicating that smoking bans on average reduced
MI incidence by 17%.
To further examine the adequacy of a random-effect
eta-analysis, a funnel plot of the estimated IRR versus the
tandard error of natural log of IRR was obtained (Fig. 2).
ocardial Infarction (Person-Year Approach)
l; IRR  incidence rate ratio.e My
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September 29, 2009:1249–55 Cardiovascular Effects of Smoking Banhe funnel plot shows asymmetry, indicating either publi-
ation bias or heterogeneity that cannot be explained by a
andom-effect meta-analysis. Contact with other investiga-
ors has not indicated the presence of unpublished peer-
eviewed studies. Meta-regression modeling showed that
eterogeneity is at least partially explained by variation in
opulation size and observation duration.
We notice that studies with smaller effect sizes (IRR close to
.0) include all non-U.S. studies and the New York State
tudy, all of which have large populations and short post-ban
urations (1 year). Meta-regression analysis was used to
xamine whether region (U.S. or non-U.S.), population size,
nd post-ban duration affect IRR. When tested separately the
ffect of population size is not significant (p  0.19), whereas
oth post-ban duration (p  0.002) and region (U.S. vs.
on-U.S., p  0.03) are significant. Post-ban duration be-
omes borderline significant (p  0.096) and region becomes
ot significant (p 0.399) when they are included in the same
odel. Because the effect of bans may not be maximal in 1
ear, it is likely that post-ban observation time is inversely
elated to IRR (effect size). This relationship is shown in
igure 3, in which the trend line illustrates the overall rela-
ionship between the estimated IRR and post-ban duration
stimated by meta-regression analysis. The size of each bubble
s proportional to the weight of the study (the inverse of the
tandard deviation of the natural log of IRR). The coefficient of
ost-ban duration in the meta-regression model is0.30 (95%
I: 0.49 to 0.11), meaning that the IRR decreases by 26%
95% CI: 10% to 39%) for each year of post-ban observation
e.g., IRR: 0.74 after 1 year, then 0.55, then 0.41 compared
ith pre-ban).
iscussion
his meta-analysis of 11 studies in 10 locations suggests
Figure 2 Funnel Plot of Estimated IRRs
A funnel plot with all points evenly distributed on both sides of the solid verti-
cal line indicates no publication bias. In this plot there are more points to the
left of the vertical line, suggesting heterogeneity caused by either variation in
length of observation or publication bias. IRR  incidence rate ratio.hat community smoking bans are associated with an overall7% reduction in risk of AMI. This is consistent with
eductions of 5% to 19% predicted by modeling (36,37). A
eta-analysis of the 4 earliest studies reported a relative risk
RR) of 0.73 (14). Subsequent meta-analysis by the same
uthor (15) included 8 studies (including an unpublished
eport noting an 11% decrease in ACS (38), which was not
sed in the current analysis) and yielded a pooled risk
eduction estimate of 19% (95% CI: 14% to 24%). The large
tudies from the Italian Piedmont (27), 4 regions (33), and
cotland (34), which observed smaller effects than the
arlier American studies, had not yet been published.
In New York, local laws were enacted beginning in 1995,
efore the implementation of a statewide law on July 24,
003. Our analysis may capture only the additive effect of
his state law, in addition to local laws, rather than the
umulative effect of local and state laws together. Because
995 is the year within 1995 to 2004 that is affected the least
y local laws, we reanalyzed the data using only 1995 as the
re-ban period, versus 2004 as the post-ban period. The
stimated IRR for New York State is only slightly smaller
han the original estimate based on all data within 1995 to
004 (0.97 vs. 0.98).
The evidence for an association between smoking bans
nd reduced AMI incidence is strengthened by beneficial
hanges in several intermediate factors: high levels of
ompliance with bans (28,35,39), decreased smoking prev-
lence and sales of tobacco (20,28,32), improved air quality
29,31,35), and reduced environmental exposure to tobacco
moke (28–30,35,40). Noteworthy is the Helena study (18),
hich documented a return to the pre-ban AMI incidence
ate in the 6 months after suspension of the ban.
Two studies determined the smoking status of AMI cases
24,34). The Indiana study (24) observed a 70% decline in
onsmokers compared with no change among smokers,
Figure 3 Bubble Plot of Estimated Effects of Smoking
Bans (Log of IRR) and the Post-Ban Duration (Years)
The size of the bubbles indicates the weight of each study in the meta-
analysis. The trend line indicates the degree to which the incidence rate ratio
(IRR) decreases as the duration of the post-ban period increases.
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Cardiovascular Effects of Smoking Ban September 29, 2009:1249–55hereas the Scottish study (34) noted a 19% to 21%
ecrease in admissions among nonsmokers and a 14%
ecrease among smokers.
The Italian 4 regions study (33) observed a reduced risk
n men only, whereas the Piedmont region (27) and Scot-
and (34) studies experienced a larger decrease in women. A
reater benefit in men might be attributed to their higher
revalence of smoking, allowing for a larger percentage to
uit. In Italy, men were more likely than women to quit
moking after the ban (41). Because the workforce has
roportionately more men, workplace bans might have a
reater effect on SHS exposure among men. Yet, a greater
ost-ban reduction in serum cotinine levels in nonsmoking
omen (47%) compared with men (37%) in Scotland (34)
uggests that exposure decreased more among women. The
elative risk associated with smoking is greater in women
han men and has a steeper dose response (42).
A greater effect in younger individuals was noted in the
tudies that evaluated age-specific incidence (27,30,33,34).
moking bans encourage cessation particularly among
oung smokers (43–45). Older individuals might benefit
ess from smoking restrictions in the workplace, bars, and
iscos. As risk of AMI associated with smoking decreases
ith age, the largest effect of eliminating SHS would occur
n younger persons.
The smaller effect size in the 5 non-U.S. studies (RR:
.95 vs. 0.75) may be partially explained by their shorter
ost-ban observation time. Additional causes might include
ifferences in AMI case definition (although a uniform
efinition has been suggested [46]), lifestyle and diet, smoking
revalence (U.S. 22.1%, Canada 21.3%, Europe 30.0%), and
ompliance. Yet, studies from Italy (47) and Ireland (48)
ndicate substantial reductions in SHS exposure.
The beneficial effect of smoking bans seems to be rapid,
ith declines in AMI incidence within 3 months (33).
mong smokers, incident ACS is reduced within days after
moking cessation (11,41). In nonsmokers, even brief expo-
ure to SHS has been associated with changes in platelet
ctivation (49–51), vascular elasticity (52), endothelial func-
ion (53), heart rate variability (54), and lipid metabolism
55,56), supporting the biological plausibility of smoking
ans’ effect on AMI.
The 11 studies are all ecological in design. Such a design
s primarily hypothesis generating. Many of these studies
iffer in case definition, SHS exposure information, smok-
ng prevalence data, and case confirmation. Many were of
hort-term duration.
The advantage of person-year analysis in the current
tudy is that analysis is based on the actual total counts of
MI events rather than the estimated average rate. Thus,
he total variation of incidence over time is considered. One
opulation estimate for each region was used regardless of
he pre- and post-ban observation times. This may explain
hy our estimates of IRR are sometimes different from the
R based on average age-adjusted rate as published in the
riginal reports. With the limited number and durations of
1tudies, we are unable to ascertain whether the IRR changes
ssociated with post-ban observation time follow a nonlin-
ar pattern, as suggested by the dose-response relationship
f SHS to AMI (10–12).
A non–peer-reviewed working paper (57) used U.S.
atabases and smoking ban implementation dates to model
he effect of workplace and public place smoking bans on
ortality and AMI admissions. The investigators found no
ignificant effect of these bans in any outcome for any age
roup. The investigators suggest that the observed benefits
n other studies are attributable to the wide variation in
ncidence related to small samples.
Although additional reports can be expected (e.g., Ireland
nd France), the 11 reports included represent the current
ndings. These studies include nearly 24 million people,
bserved 215,524 cardiac events, and suggest that commu-
ity smoking bans are associated with a 17% reduction in
MI incidence. If this association represents a cause-and-
ffect relationship, and assuming approximately 920,000
ncident AMIs each year in the U.S., a nationwide ban on
ublic smoking might ultimately prevent as many as
56,400 new AMIs yearly.
eprint requests and correspondence: Dr. David G. Meyers,
ivision of Cardiovascular Diseases, Kansas University School of
edicine, 3901 Rainbow Boulevard, Kansas City, Kansas 66160.
-mail: dmeyers@kumc.edu.
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